Entity Details
| Primary name |
NYX_HUMAN |
| Entity type |
UniProt |
| Source |
Source Link |
Details
| Accession | Q9GZU5 |
| EntryName | NYX_HUMAN |
| FullName | Nyctalopin |
| TaxID | 9606 |
| Evidence | evidence at protein level |
| Length | 481 |
| SequenceStatus | complete |
| DateCreated | 2002-09-19 |
| DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
| Subcellular Location |
| Secreted |
Domains
Show/Hide Table
| Domain | Name | Category | Type |
| IPR000372 | Leucine-rich repeat N-terminal domain | Domain | Domain |
| IPR000483 | Cysteine-rich flanking region, C-terminal | Domain | Domain |
| IPR001611 | Leucine-rich repeat | Repeat | Repeat |
| IPR003591 | Leucine-rich repeat, typical subtype | Repeat | Repeat |
| IPR032675 | Leucine-rich repeat domain superfamily | Family | Homologous superfamily |
Diseases
Show/Hide Table
| Disease ID | Source | Name | Description |
| 310500 | OMIM | Night blindness, congenital stationary, 1A (CSNB1A) | A non-progressive retinal disorder characterized by impaired night vision. Congenital stationary night blindness type 1A is characterized by impaired scotopic vision, myopia, hyperopia, nystagmus and reduced visual acuity. The disease is caused by variants affecting the gene represented in this entry. |
Interactions
2 interactions